Chronic migraine can be difficult to treat — but new research is helping identify the most effective options.

In a large new review, published today in the Annals of Internal Medicine, researchers analyzed 43 clinical trials involving adults with chronic migraine, defined as headaches on 15 or more days a month.

The st... Full Page

Alcoholic beverages in the United States carry a warning label, but you’d be forgiven if they leave little impression.

In place since 1988, the label states the risks of drinking during pregnancy or while driving, along with a general notice that alcohol “may cause health problems.”

These small labels often go unnot... Full Page

A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped working, according to a pair of new studies.

The treatment combines two drugs already approved to treat inflammatory diseases, guselkubam (Tremfya) and golimumab (Simponi), researchers are reporting today at a joint ... Full Page

Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded.

People with alcohol use disorder taking semaglutide (Ozempic/Wegovy) had significantly fewer heavy drinking days compared to patients assigned a placebo, researchers reported May 2 in The Lancet. 

People on semaglutide also dr... Full Page